OpenAI released GPT-Rosalind today, a frontier reasoning model purpose-built for life sciences research, available in trusted-access preview to customers like Amgen, Moderna, and the Allen Institute.

On the benchmarks, it's competent rather than revolutionary, leading on… https://t.co/BL9RnVlJ2Z

— Chubby♨️ (@kimmonismus) 16 avril 2026

OpenAI released GPT-Rosalind today, a frontier reasoning model purpose-built for life sciences research, available in trusted-access preview to customers like Amgen, Moderna, and the Allen Institute. On the benchmarks, it's competent rather than revolutionary, leading on

→ View original post on X — @kimmonismus,